Assessment of antiarrhythmic drug efficacy in the treatment of supraventricular arrhythmias
- 29 August 1986
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 58 (5) , C31-C36
- https://doi.org/10.1016/0002-9149(86)90101-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.Circulation, 1984
- Crossover and Self-Controlled Designs in Clinical ResearchNew England Journal of Medicine, 1984
- Life-table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal atrial tachycardiaThe American Journal of Cardiology, 1983
- Electrophysiology of oral encainideThe American Journal of Cardiology, 1982
- Oral Verapamil for Paroxysmal Supraventricular TachycardiaAnnals of Internal Medicine, 1982
- Electrocardiogram Recording By Telephone in Antiarrhythmic Drug TrialsChest, 1982
- Spontaneous termination of circus movement tachycardia using an atrioventricular accessory pathway: incidence, site of block and mechanisms.Circulation, 1981
- Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or FlutterAnnals of Internal Medicine, 1981
- Serial electrophysiologic testing of multiple drugs in patients with atrioventricular nodal reentrant paroxysmal tachycardia.Circulation, 1980
- Ventricular Fibrillation in the Wolff-Parkinson-White SyndromeNew England Journal of Medicine, 1979